Teladoc Health, Inc. TDOC
6.09
(0.05)
(0.81%)
as of 25 Sep
- Market cap
- $1.1B
- P/E
- 0.0×
Follow TDOC
Insider Buys
alert about insiders buying in the last 12 month
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
5.67 | 8.60 | 7.81 | 10.87 | 16.54 | 7.09 | 1.51 | 1.39 | 0.60 | 0.49 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 519.46 | 0.00 | 193.02 | 0.00 | 99.71 | 25.91 | 8.98 |
P/Operating CF |
(92.71) | (275.80) | 1,318.23 | 331.91 | (157.46) | 173.18 | 55.62 | 27.75 | 18.05 | 14.06 |
P/B ratio |
3.03 | 3.59 | 3.22 | 5.93 | 1.14 | 0.90 | 1.58 | 1.55 | 1.04 | 0.89 |
Price to Tangible BV |
39.22 | 0.00 | 114.41 | 141.55 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
5.50 | 8.97 | 7.66 | 10.74 | 17.12 | 7.26 | 1.78 | 1.55 | 0.70 | 0.79 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 967.83 | 246.04 | 40.28 | 11.81 | 10.79 |
EV/Operating CF |
(13.05) | (60.79) | (658.87) | 198.98 | (350.09) | 76.05 | 22.59 | 11.53 | 6.11 | 6.79 |
EV/FCF |
(11.96) | (48.87) | (263.92) | 513.27 | (184.44) | 197.61 | (30.60) | 111.48 | 29.98 | 14.55 |
Quick Ratio |
3.78 | 3.70 | 8.36 | 6.37 | 2.87 | 3.22 | 2.82 | 3.19 | 1.61 | 2.41 |
Current Ratio |
3.93 | 3.87 | 8.53 | 6.52 | 3.19 | 3.70 | 3.29 | 3.54 | 1.77 | 2.77 |
Net Debt/EBITDA |
0.46 | (2.38) | 4.05 | 7.13 | (1.66) | 22.48 | 36.31 | 4.14 | 1.60 | 1.15 |
Debt/Assets |
14.63% | 25.15% | 27.12% | 27.79% | 8.01% | 6.98% | 35.65% | 35.03% | 43.85% | 34.81% |
Debt/Equity |
0.19 | 0.37 | 0.41 | 0.44 | 0.09 | 0.08 | 0.67 | 0.66 | 1.03 | 0.72 |
Asset Turnover |
0.46 | 0.41 | 0.36 | 0.35 | 0.11 | 0.11 | 0.22 | 0.60 | 0.65 | 0.79 |
Operating CF/Net income |
0.70 | 0.32 | 0.05 | (0.30) | 0.11 | (0.45) | (0.01) | (1.59) | (0.29) | (1.47) |
Capex/Depreciation |
(0.29) | (0.21) | (0.13) | (0.26) | (0.39) | (0.42) | (0.02) | (0.45) | (0.11) | (0.35) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (36.25%) | (27.04%) | (12.35%) | (9.75%) | (5.74%) | (2.69%) | (148.85%) | (9.51%) | (52.46%) | (13.93%) | |
| (27.83%) | (18.93%) | (8.25%) | (6.31%) | (5.01%) | (2.42%) | (123.73%) | (5.04%) | (25.32%) | (6.28%) | |
ROIC |
(18.70%) | (7.32%) | (4.67%) | (5.34%) | (1.92%) | (1.01%) | (290.36%) | (5.67%) | (36.78%) | (10.27%) |
Return on Tangible Assets |
(107.37%) | (85.51%) | (20.21%) | (19.46%) | (64.21%) | (46.52%) | (1,445.06%) | (20.03%) | (133.17%) | (27.02%) |
Average Days of Receivables |
40.92 | 42.39 | 38.05 | 37.57 | 56.48 | 30.34 | 31.93 | 30.49 | 30.42 | 27.82 |
Research and Development Expense of Revenue |
17.71% | 14.77% | 13.01% | 11.68% | 15.08% | 15.34% | 13.86% | 13.39% | 11.96% | 10.99% |
Selling, General and Administrative Expense of Revenue |
88.94% | 75.20% | 62.50% | 61.28% | 81.07% | 54.38% | 54.04% | 52.54% | 52.39% | 50.58% |
Intangible Assets out of Total Assets |
0.70 | 0.80 | 0.64 | 0.61 | 0.94 | 0.93 | 0.67 | 0.63 | 0.49 | 0.55 |
Share Based Compensation of Revenue |
6.27% | 13.12% | 10.47% | 12.06% | 43.47% | 14.89% | 9.05% | 7.74% | 5.68% | 3.18% |
Graham Net Nets |
0.01 | (0.05) | 0.01 | 0.00 | (0.04) | (0.03) | (0.20) | (0.16) | (0.23) | (0.29) |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(10.55%) | (5.22%) | (2.99%) | (1.65%) | (2.68%) | (3.02%) | (375.29%) | (6.11%) | (64.69%) | (16.29%) |
Free Cash Flow Yield |
(8.10%) | (2.14%) | (0.37%) | 0.19% | (0.56%) | 0.52% | (3.83%) | 1.00% | 3.86% | 11.13% |
Revenue per Share |
2.91 | 4.21 | 6.35 | 7.70 | 12.09 | 12.95 | 14.91 | 15.81 | 15.07 | 14.36 |
Operating CF per Share |
(1.23) | (0.62) | (0.07) | 0.42 | (0.59) | 1.24 | 1.17 | 2.13 | 1.72 | 1.67 |
Capex per Share |
(0.11) | (0.15) | (0.11) | (0.25) | (0.53) | (0.76) | (2.04) | (0.95) | (0.73) | (0.89) |
Free Cash Flow per Share |
(1.34) | (0.77) | (0.18) | 0.16 | (1.12) | 0.48 | (0.87) | 1.18 | 0.99 | 0.78 |
Cash per Share |
1.55 | 2.21 | 7.27 | 7.20 | 8.69 | 5.71 | 5.69 | 6.83 | 7.61 | 4.43 |
Shareholders Equity per Share |
5.45 | 10.08 | 15.39 | 14.11 | 175.49 | 102.24 | 14.29 | 14.13 | 8.74 | 7.86 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
5.45 | 10.08 | 15.39 | 14.11 | 175.49 | 102.24 | 14.29 | 14.13 | 8.74 | 7.86 |
Free Cash Flow |
(56.59) | (42.84) | (12.13) | 11.58 | (101.57) | 74.66 | (139.76) | 193.67 | 169.63 | 137.33 |
Working Capital |
61.64 | 115.91 | 470.30 | 497.82 | 726.96 | 894.43 | 915.62 | 1,068.43 | 722.37 | 714.39 |
Capital Expenditures |
(4.72) | (8.40) | (7.27) | (18.29) | (48.06) | (119.33) | (329.05) | (156.35) | (124.05) | (157.02) |
Net Current Asset Value |
9.92 | (109.25) | 16.98 | (0.80) | (811.87) | (463.41) | (722.22) | (577.25) | (361.54) | (353.46) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.04 | 0.04 | 0.02 | 0.03 | 0.04 | 0.06 | 0.14 | 0.06 | 0.05 | 0.06 |
Net Profit Margin |
(60.26%) | (45.77%) | (23.23%) | (17.87%) | (44.35%) | (21.09%) | (567.53%) | (8.47%) | (38.97%) | (7.92%) |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
2.17 | 4.42 | 5.43 | 6.84 | 4.32 | 10.31 | 461.21 | 10.89 | 39.77 | 16.62 |
Cash ROIC |
(17.40%) | (4.88%) | (0.79%) | 0.99% | (0.45%) | 0.92% | 3.34% | 6.37% | 6.10% | 8.46% |
Accounts Receivable Turnover |
9.50 | 11.41 | 11.83 | 11.01 | 9.67 | 12.02 | 12.68 | 12.16 | 11.91 | 12.43 |
Accounts Payable Turnover |
14.37 | 20.14 | 22.09 | 21.90 | 14.18 | 13.94 | 15.67 | 16.64 | 19.57 | 19.03 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 6.06 | 10.04 | 11.50 | 17.71 | 22.21 | 20.21 |
Average Days of Payables |
25.53 | 23.01 | 22.03 | 17.96 | 42.99 | 26.53 | 23.40 | 20.96 | 16.10 | 22.69 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 52.76 | 41.02 | 27.64 | 14.17 | 18.53 | 18.07 |
Average Receivables |
12.97 | 20.45 | 35.33 | 50.26 | 113.11 | 169.12 | 189.76 | 213.99 | 215.78 | 203.49 |
Average Payables |
2.22 | 3.06 | 5.83 | 8.42 | 27.55 | 46.64 | 47.47 | 45.66 | 38.38 | 40.55 |
Average Inventory |
— | — | — | — | 64.50 | 64.79 | 64.71 | 42.93 | 33.83 | 38.17 |
Average Assets |
266.70 | 564.03 | 1,176.63 | 1,565.85 | 9,679.05 | 17,744.95 | 11,039.98 | 4,368.86 | 3,954.45 | 3,187.41 |
Average Common Equity |
204.72 | 394.89 | 786.01 | 1,013.57 | 8,448.91 | 15,964.78 | 9,176.75 | 2,316.91 | 1,908.58 | 1,438.39 |
Columns are period end dates